| 2026-08-18 | Press release | Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Sc |
| 2026-08-03 | Press release | Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies |
| 2026-06-22 | Press release | Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combinat |
| 2026-04-30 | Press release | Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibo |
| 2026-04-21 | Presentation | Download |
| 2026-04-15 | Presentation | Download |
| 2026-02-10 | Press release | Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibo |
| 2026-01-01 | Press release | Genprex Collaborators Selected to Present Positive Preclinical Data on Diabetes Gene Therapy at the 2025 American Diabet |
| 2026-01-01 | Press release | Genprex to Participate at BIO Europe Spring 2025 |
| 2025-06-12 | Presentation | Download |
| 2025-04-20 | Fact sheet | Download |
| 2023-10-12 | Presentation | Download |
| 2023-02-28 | Presentation | Download |
| Press release | Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeti |
| Press release | Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 America |
| Press release | Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 Amer |
| Press release | Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual |
| Press release | Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therap |
| Press release | Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Ca |
| Press release | Genprex Provides Clinical Update on Diabetes Gene Therapy Program |
| Press release | Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies |
| Press release | Data from Genprex’s Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer |
| Press release | Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials |
| Press release | Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Can |
| Press release | Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules |
| Press release | Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung |
| Press release | Genprex Announces Registered Direct Offering of up to $8.2 Million Priced At-The-Market Under Nasdaq Rules |
| Press release | Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung |
| Press release | Genprex to Present and Participate at Upcoming September Investor and Industry Conferences |
| Press release | Genprex Issues Stockholder Letter and Provides 2025 Corporate Update |
| Press release | Genprex Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy at the 2025 American Diabetes Assoc |
| Press release | Genprex Collaborators Present Research on Non-Viral Approach to Diabetes Gene Therapy Using Lipid Nanoparticle Delivery |
| Press release | Genprex to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer a |
| Press release | Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting |
| Press release | Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 an |
| Press release | Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Gliobla |
| Press release | Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhi |
| Press release | Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting |
| Press release | Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesoth |
| Press release | Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung |